Esophageal cancer linked to osteoporosis drugs
Wednesday, December 31, 2008 - 17:35
in Health & Medicine
BOSTON (Reuters) - Merck's popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer, a Food and Drug Administration official said on Wednesday.